|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SPACELABS MEDICAL INC, 10-Q, EX-10.48, 2000-11-14 |
Next: LIGAND PHARMACEUTICALS INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 3,578
<SECURITIES> 0
<RECEIVABLES> 66,776
<ALLOWANCES> 3,110
<INVENTORY> 78,803
<CURRENT-ASSETS> 180,443
<PP&E> 134,103
<DEPRECIATION> 73,227
<TOTAL-ASSETS> 276,892
<CURRENT-LIABILITIES> 41,309
<BONDS> 71,648
0
0
<COMMON> 113
<OTHER-SE> 161,586
<TOTAL-LIABILITY-AND-EQUITY> 276,892
<SALES> 184,095
<TOTAL-REVENUES> 184,095
<CGS> 105,007
<TOTAL-COSTS> 105,007
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 546
<INTEREST-EXPENSE> 4,205
<INCOME-PRETAX> (9,947)
<INCOME-TAX> (3,855)
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (6,092)
<EPS-BASIC> (0.64)
<EPS-DILUTED> (0.64)
</TABLE>
|
|